期刊文献+

益元清肝健运汤治疗2型糖尿病并高脂血症的临床疗效观察 被引量:2

Clinical Observation of Liver Yiyuan Tang Jian Yun Treatment of Type 2 Diabetes and Hyperlipidemia
下载PDF
导出
摘要 目的分析益元清肝健运汤治疗2型糖尿病并高脂血症的临床疗效。方法回顾性的选择2015年2月—2016年5月该院收治89例2型糖尿病并高脂血症患者临床资料,根据治疗时所采用不同方法分为两组,对照组40例给予西医综合方法,研究组49例给予益元清肝健运汤,对比两组血糖、血脂水平。结果研究组FBG、P2 h BG、Hb A1c水平低于对照组(P<0.05);研究组TC、TG、LDC-C水平比对照组低,HDL-C水平比对照组高(P<0.05)。结论 2型糖尿病并高脂血症应用益元清肝健运汤治疗能有效降低血糖,同时调整血脂,具有实用价值。 Objective To analyze the health movement Tang Yi Yuan Liver treatment of type 2 diabetes and hyperlipidemia clinical efficacy. Methods Retrospective Selection February 2015- May 2016 our hospital 89 cases of type 2 diabetes and hyperlipidemia hyperlipidemia patients with clinical data, according to the different treatment methods,the patients are divided into two groups, a control group of 40 patients given western medicine integrated approach, study group of 49 patients given Liver health movement Yiyuan Tang, compared two groups of blood glucose and lipid levels. Results The study group FBG, P2 h BG, Hb A1 c levels than the control group(P〈0.05); the study group TC, TG, LDC-C levels lower than the control group, HDL-C levels higher than the control group(P〈0.05). Conclusion Type 2 diabetes and hyperlipidemia application Yiyuan Tang Liver health movement therapy can effectively lower blood sugar, while adjusting lipids, has practical value.
作者 邓培友 高荔
出处 《糖尿病新世界》 2016年第17期55-56,共2页 Diabetes New World Magazine
关键词 益元清肝健运汤 2型糖尿病 高脂血症 疗效 Liver health movement Yiyuan Tang Type 2 diabetes Hyperlipidemia Efficacy
  • 相关文献

参考文献5

二级参考文献39

  • 1王玉仙,马学荣.泽泻汤加味治疗高脂血症103例[J].陕西中医,2005,26(2):103-104. 被引量:14
  • 2梁永.调脂降糖汤治疗2型糖尿病高脂血症临床观察[J].中国中医急症,2005,14(4):304-305. 被引量:3
  • 3程比奇.中医学[M].北京:人民卫生出版社,2000:154.
  • 4郑筱萸.中药新药临床研究指导原则[M]第1版[M].北京:中国医药科技出版社,2002.69-73.
  • 5莫莉莉.防治动脉粥样硬化症中草药的研究.广东医学,1988,(3):33-33.
  • 6国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2000:89.
  • 7D'Ominguec JH,Tang N,Xu W ,et al. Studies of renal injury Ⅲ : lipid induced nephropathy In type Ⅱ diabetes [J]. Kidney Int, 2000,57 : 92-99.
  • 8Levin K, Schroeder HD, Alford FP, et al. Morpho- metric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes[J] . Diabetologia, 2001,44 (7) : 824- 833.
  • 9Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease -The common soil hypothesis re- visited[J]. Arteriosclerosis , 2004,11 (1) : 1-11.
  • 10MeGarry JD. Banting lecture2001 : dysregulation of fatty acid metabolism in the etiology of type2 diabetes[J]. Diabetes,2002,75(12) : 3972-3979.

共引文献36

同被引文献11

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部